FindTrial
Sign In

PSMA PET/CT scan

DIAGNOSTIC_TEST6 trials

Sponsors

British Columbia Cancer Agency, OHSU Knight Cancer Institute, Jiequn Yu, Royal North Shore Hospital, IRCCS Azienda Ospedaliero-Universitaria di Bologna

Conditions

Castration Resistant Prostate CancerCastration Sensitive Prostate CancerGlioblastomaGlioblastoma Multiforme (GBM)PSMA Positive Tumors or Tumor TissuesPositron Emission Tomography (PET)Prostate AdenocarcinomaProstate Cancer

Phase 4

Evaluation of the Change in PSMA Expression in Prostate Cancer in Response to Hormonal Therapy
RecruitingNCT05919329
OHSU Knight Cancer InstituteCastration Resistant Prostate Cancer, Castration Sensitive Prostate Cancer, Prostate Adenocarcinoma
Start: 2024-06-25End: 2030-09-01Target: 80Updated: 2025-10-24

Unknown Phase

PSMA PET/CT for Assessment of Recurrent Prostate Cancer
Active, not recruitingNCT02899312
British Columbia Cancer AgencyProstate Cancer, Prostatic Neoplasms
Start: 2017-03-16End: 2030-06-30Target: 2244Updated: 2024-11-07
Intratumoral Heterogeneity on [18F]PSMA and [18F]FDG PET/CT in Predicting Invasion and Prognosis of Prostate Cancer
CompletedNCT06919159
Jiequn YuPositron Emission Tomography (PET), Prostate Cancer (Diagnosis), Prostate-specific Membrane Antigen
Start: 2021-07-01End: 2022-11-30Updated: 2025-04-11
The Effect of Glioblastoma PSMA Expression Following Tumour VEGF Blockade From Bevacizumab
RecruitingNCT07052877
Royal North Shore HospitalGlioblastoma, Glioblastoma Multiforme (GBM)
Start: 2025-12-11End: 2027-07-01Target: 20Updated: 2026-08-13
PSMA PET for Treatment Response evaLuation of systemIC Therapies in prostAte caNcer (PELICAN)
RecruitingNCT07089550
IRCCS Azienda Ospedaliero-Universitaria di BolognaProstate Cancer Metastatic, PSMA Positive Tumors or Tumor Tissues
Start: 2025-04-02End: 2034-04-26Target: 1300Updated: 2026-02-20
PSMA PET for Surveillance After Focal Therapy
RecruitingNCT07115914
University of ChicagoProstate Cancer (Adenocarcinoma), Prostate Cancer (Diagnosis), Prostate Cancer Metastatic Disease
Start: 2025-11-19End: 2028-08-01Target: 62Updated: 2026-02-17

Related Papers

Prognostic significance of a negative PSMA PET/CT in biochemical recurrence of prostate cancer.
2024-08-305 citations
Outcome of patients with biochemical recurrence of prostate cancer after PSMA PET/CT-directed radiotherapy or surgery without systemic therapy.
2023-03-1716 citations
Patterns of Prostate Cancer Recurrence After Brachytherapy Determined by Prostate-Specific Membrane Antigen-Positron Emission Tomography and Computed Tomography Imaging.
2022-01-029 citations